Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. On July 31, 2026, the company's wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical Co., Ltd. (hereinafter referred to as “Yipinhong Pharmaceutical”) and Guangzhou Lianrui Pharmaceutical Co., Ltd. (hereinafter referred to as “Lianrui Pharmaceutical”) participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office. Yipinhong Pharmaceutical used injectable isaconazole sulfate and Lianrui Pharmaceuticals to pass the consistent evaluation of generic drug quality and efficacy. Ammonia chloride Horizon Film (III) plans to win the bid for this centralized procurement.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. On July 31, 2026, the company's wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical Co., Ltd. (hereinafter referred to as “Yipinhong Pharmaceutical”) and Guangzhou Lianrui Pharmaceutical Co., Ltd. (hereinafter referred to as “Lianrui Pharmaceutical”) participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office. Yipinhong Pharmaceutical used injectable isaconazole sulfate and Lianrui Pharmaceuticals to pass the consistent evaluation of generic drug quality and efficacy. Ammonia chloride Horizon Film (III) plans to win the bid for this centralized procurement.